Regeneron Pharmaceuticals, Inc. is a prominent American biotechnology firm headquartered in Westchester County, New York, renowned for its pioneering research and development in monoclonal antibodies and therapeutic proteins. With a diverse portfolio that spans critical therapeutic areas such as oncology, ophthalmology, and immunology, Regeneron is celebrated for its flagship products, including Eylea and Dupixent. The company boasts a strong and innovative pipeline, reflecting its unwavering commitment to scientific excellence and its position as a major contributor to the biopharmaceutical sector, consistently delivering groundbreaking therapies to meet significant unmet medical needs.